Replacement Announcement - Investor Presentation March 2025

Open PDF
Stock Nagambie Resources Ltd (NAG.ASX)
Release Time 12 Mar 2025, 11:32 a.m.
Price Sensitive Yes
 Nagambie Resources Investor Presentation March 2025
Key Points
  • Flagship Nagambie Antimony-Gold Project with Australia's highest-grade antimony JORC Inferred Resource
  • Permitting to develop a toll processing plant completed
  • Significant upside potential with increasing depth and strike extension drilling
Full Summary

Nagambie Resources is an exploration company targeting epizonal gold and antimony mineralized systems across 1,000 sq km of tenements in the Waranga Domain of the Melbourne Structural Zone, Victoria, Australia. The company's flagship project is the Nagambie Antimony-Gold Project, which contains Australia's highest-grade antimony JORC Inferred Resource, located at the 100% owned Nagambie Mine. The project has a mining licence in place, and the company has completed permitting to develop a toll processing plant. Recent achievements include a maiden JORC Inferred Resource, with the majority of the model blocks between 80m and 280m vertical depth, indicating significant upside potential with increasing depth. The company is focused on growing the JORC Inferred Resource through strike and depth extension drilling, with plans to update the resource estimates, advance permitting of the decline and associated underground development, and commence a project scoping study in the next 12 months. Nagambie has also formed a joint venture, the Nagambie Joint Venture (NJV), to develop a central processing hub at the Nagambie Mine site, including an Au-Sb processing plant, renewable energy hub, and tailings repurposing initiatives.

Outlook

Nagambie Resources is focused on growing its JORC Inferred Resource at the Nagambie Antimony-Gold Project through strike and depth extension drilling. The company plans to update the resource estimates, advance permitting of the decline and associated underground development, and commence a project scoping study in the next 12 months.